Insight Molecular Diagnostics Inc. (IMDX) Gross profit 2020–2025
Insight Molecular Diagnostics Inc. (IMDX) annual gross profit history from SEC filings — each fiscal year as reported.
$2.3MFY2025 · since FY2020: -$639,000 → $2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.3M | +210.5% |
| FY2024 | $740,000 | +79.2% |
| FY2023 | $413,000 | +2394.4% |
| FY2022 | -$18,000 | -101.3% |
| FY2021 | $1.4M | +322.2% |
| FY2020 | -$639,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMDX financial trends
IMDX RevenueIMDX Net incomeIMDX Net marginIMDX Gross marginIMDX Operating incomeIMDX Operating marginIMDX Operating cash flowIMDX Free cash flowIMDX Capital expendituresIMDX Return on equityIMDX Stock buybacksIMDX Dividends paidIMDX Total assetsIMDX Total liabilitiesIMDX Shareholders’ equityIMDX overview →